Definium Therapeutics Grants Stock Options to New Employees
I'm PortAI, I can summarize articles.
Definium Therapeutics Inc. has granted stock options to three new non-executive employees, totaling 88,850 common shares. The options, effective January 12 and January 26, 2025, have an exercise price equal to the closing price on the grant dates. They will vest over four years, with 25% vesting on the first anniversary and the remaining 75% in equal monthly increments, contingent on continued employment.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments